JP2005504829A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005504829A5 JP2005504829A5 JP2003532646A JP2003532646A JP2005504829A5 JP 2005504829 A5 JP2005504829 A5 JP 2005504829A5 JP 2003532646 A JP2003532646 A JP 2003532646A JP 2003532646 A JP2003532646 A JP 2003532646A JP 2005504829 A5 JP2005504829 A5 JP 2005504829A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- inhibitor
- seq
- camkii
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32657601P | 2001-10-01 | 2001-10-01 | |
| US32801001P | 2001-10-08 | 2001-10-08 | |
| PCT/US2002/031496 WO2003029428A2 (en) | 2001-10-01 | 2002-10-01 | Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005504829A JP2005504829A (ja) | 2005-02-17 |
| JP2005504829A5 true JP2005504829A5 (https=) | 2007-10-18 |
Family
ID=26985461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003532646A Pending JP2005504829A (ja) | 2001-10-01 | 2002-10-01 | 構造的心疾患における心筋機能不全を処置するためのカルモジュリンキナーゼｉｉインヒビターの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7320959B2 (https=) |
| EP (1) | EP1439849A4 (https=) |
| JP (1) | JP2005504829A (https=) |
| KR (1) | KR20040045041A (https=) |
| CN (1) | CN1599622A (https=) |
| AU (1) | AU2002341938B2 (https=) |
| BR (1) | BR0213043A (https=) |
| CA (1) | CA2462443A1 (https=) |
| IL (1) | IL161231A0 (https=) |
| MX (1) | MXPA04003040A (https=) |
| NO (1) | NO20041331L (https=) |
| NZ (1) | NZ532327A (https=) |
| PL (1) | PL369104A1 (https=) |
| WO (1) | WO2003029428A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1815867A4 (en) * | 2004-11-02 | 2010-06-09 | Dainippon Sumitomo Pharma Co | COMBINATION PREPARATION FOR THE TREATMENT OF AUTOIMMUNE DISEASE |
| JP5415520B2 (ja) * | 2008-04-09 | 2014-02-12 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 最大酸素消費量低下の予測のためのプロ−エンドセリン−１ |
| US8841423B2 (en) * | 2008-04-28 | 2014-09-23 | University Of Iowa Research Foundation | Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II |
| US20090275514A1 (en) * | 2008-05-01 | 2009-11-05 | Anderson Mark E | Use of calmodulin kinase ii inhibitors to treat or prevent heart muscle inflammation |
| US20120134971A1 (en) * | 2009-05-22 | 2012-05-31 | The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services | Engineered biological pacemakers |
| US8440656B2 (en) * | 2009-06-22 | 2013-05-14 | University Of Iowa Research Foundation | Methods of treating pulmonary diseases and disorders by modulating calcium/calmodulin dependent protein kinase II activity |
| EP2485749A4 (en) * | 2009-10-05 | 2013-07-24 | Univ Cornell | METHOD FOR THE PREVENTION AND TREATMENT OF HEART FAILURE |
| AU2014225889B2 (en) | 2013-03-06 | 2018-12-06 | The Johns Hopkins University | CaMKII inhibitors and uses thereof |
| DE102014201651A1 (de) * | 2014-01-30 | 2015-07-30 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Isoxazolderivate zur Verwendung bei der Behandlung und/oder Prophylaxe von Herzerkrankungen |
| WO2016037106A1 (en) | 2014-09-05 | 2016-03-10 | Allosteros Therapeutics, Inc | CaMKII INHIBITORS AND USES THEREOF |
| WO2018031771A1 (en) | 2016-08-11 | 2018-02-15 | University Of Iowa Research Foundation | CATIONIC CaMKII INHIBITING NANOPARTICLES FOR THE TREATMENT OF ALLERGIC ASTHMA |
| CN112972447B (zh) * | 2021-03-02 | 2022-09-23 | 扬州大学附属医院 | CaMK II抑制剂在制备预防和/或治疗急性胰腺炎的药物中的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1601438A (https=) | 1968-10-17 | 1970-08-24 | ||
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| JP2001509808A (ja) * | 1997-01-31 | 2001-07-24 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 多機能性カルシウム／カルモジュリン−依存性プロテインキナーゼの阻害による不整脈の処置 |
| JP2963986B2 (ja) * | 1997-11-19 | 1999-10-18 | 工業技術院長 | カルモジュリン依存性リン酸化酵素ｉｉの特異的阻害剤 |
-
2002
- 2002-10-01 US US10/491,323 patent/US7320959B2/en not_active Expired - Fee Related
- 2002-10-01 NZ NZ532327A patent/NZ532327A/en unknown
- 2002-10-01 IL IL16123102A patent/IL161231A0/xx unknown
- 2002-10-01 AU AU2002341938A patent/AU2002341938B2/en not_active Ceased
- 2002-10-01 EP EP02776099A patent/EP1439849A4/en not_active Withdrawn
- 2002-10-01 CA CA002462443A patent/CA2462443A1/en not_active Abandoned
- 2002-10-01 KR KR10-2004-7004775A patent/KR20040045041A/ko not_active Withdrawn
- 2002-10-01 PL PL02369104A patent/PL369104A1/xx not_active Application Discontinuation
- 2002-10-01 BR BR0213043-2A patent/BR0213043A/pt not_active IP Right Cessation
- 2002-10-01 MX MXPA04003040A patent/MXPA04003040A/es not_active Application Discontinuation
- 2002-10-01 CN CNA028241010A patent/CN1599622A/zh active Pending
- 2002-10-01 WO PCT/US2002/031496 patent/WO2003029428A2/en not_active Ceased
- 2002-10-01 JP JP2003532646A patent/JP2005504829A/ja active Pending
-
2004
- 2004-03-31 NO NO20041331A patent/NO20041331L/no not_active Application Discontinuation
-
2007
- 2007-11-13 US US11/983,987 patent/US7632815B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101718639B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| EP0741567B1 (en) | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds | |
| US20040209891A1 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase IV | |
| JP2005504829A5 (https=) | ||
| KR20200111822A (ko) | 심방 확장 또는 재형성을 특징으로 하는 질환을 치료하기 위한 nep 억제제 | |
| JPH04226914A (ja) | 狭心症治療用バクロフェン | |
| TWI908718B (zh) | 類鐸受體促效劑給藥方案 | |
| JP5643213B2 (ja) | 肥大性心筋症治療用のホスホジエステラーゼタイプＩＩＩ（ＰＤＥＩＩＩ）インヒビターまたはＣａ２＋感作剤 | |
| JP2008510705A5 (https=) | ||
| US20080153827A1 (en) | Method for the Treatment or Prevention of Cardiac Hypertrophy | |
| CN86107813A (zh) | 制备用作强心剂的杂环唑酮类的方法 | |
| CN86107814A (zh) | 制备用作强心剂的噻唑酮的方法 | |
| JP2000513341A (ja) | 血管拡張剤を使用する肝疾患および類似の徴候の治療法 | |
| JP2003277265A (ja) | ｅＮＯＳ発現に起因する疾患の予防または治療薬 | |
| CN1181699A (zh) | 用于治疗心血管疾病的氨基四氢化萘衍生物 | |
| Fauville et al. | Severe diltiazem poisoning with intestinal pseudo-obstruction: case report and toxicological data | |
| US20150038489A1 (en) | Compound and methods for treating long qt syndrome | |
| Monge Utrilla et al. | Canine Dilated Cardiomyopathy Secondary to Hypothyroidism: Review of 3 Clinical Cases | |
| JP4802470B2 (ja) | 肝線維化抑制剤 | |
| ES2286595T3 (es) | Combinacion de farmacos antidiabeticos. | |
| NZ190028A (en) | Pharmaceutical compositions containing a dibenzothiazepine | |
| US20060142354A1 (en) | Use of epothilone derivatives for the treatment of hyperparathyroidism | |
| Tsuda | Clinical Improvement in a Young Patient with Hypertrophic Obstructive Cardiomyopathy Treated with Combination Therapy Including Amiodarone. Case Rep Case Ser Cardiol J. October-December 2025; 01 (03): 71-77 | |
| US20040023975A1 (en) | Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome | |
| CA2489545A1 (en) | Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome |